169 related articles for article (PubMed ID: 29552119)
1. MicroRNA-374b inhibits liver cancer progression via down regulating programmed cell death-1 expression on cytokine-induced killer cells.
Huang F; Wang B; Zeng J; Sang S; Lei J; Lu Y
Oncol Lett; 2018 Apr; 15(4):4797-4804. PubMed ID: 29552119
[TBL] [Abstract][Full Text] [Related]
2. MiR-374b increases the CIK expression and mediates biological function changes in cervical cancer cells by targeting the PD-1/PD-L1 signaling pathway.
Wang C; Kuang L; Han L
J Reprod Immunol; 2021 Feb; 143():103265. PubMed ID: 33360511
[TBL] [Abstract][Full Text] [Related]
3. Programmed Death Receptor 1 (PD1) Knockout and Human Telomerase Reverse Transcriptase (hTERT) Transduction Can Enhance Persistence and Antitumor Efficacy of Cytokine-Induced Killer Cells Against Hepatocellular Carcinoma.
Huang K; Sun B; Luo N; Guo H; Hu J; Peng J
Med Sci Monit; 2018 Jul; 24():4573-4582. PubMed ID: 29967316
[TBL] [Abstract][Full Text] [Related]
4. Programmed cell death protein-1/programmed death-ligand 1 blockade enhances the antitumor efficacy of adoptive cell therapy against non-small cell lung cancer.
Chen J; Chen Y; Feng F; Chen C; Zeng H; Wen S; Xu X; He J; Li J
J Thorac Dis; 2018 Dec; 10(12):6711-6721. PubMed ID: 30746216
[TBL] [Abstract][Full Text] [Related]
5. Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.
Dai C; Lin F; Geng R; Ge X; Tang W; Chang J; Wu Z; Liu X; Lin Y; Zhang Z; Li J
Oncotarget; 2016 Mar; 7(9):10332-44. PubMed ID: 26871284
[TBL] [Abstract][Full Text] [Related]
6. A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines.
Li Y; Sharma A; Wu X; Weiher H; Skowasch D; Essler M; Schmidt-Wolf IGH
Front Oncol; 2022; 12():713476. PubMed ID: 35646685
[TBL] [Abstract][Full Text] [Related]
7. PD-1 blockade enhances cytokine-induced killer cell-mediated cytotoxicity in B-cell non-Hodgkin lymphoma cell lines.
Li Y; Sharma A; Bloemendal MWJR; Schmidt-Wolf R; Kornek M; Schmidt-Wolf IGH
Oncol Lett; 2021 Aug; 22(2):613. PubMed ID: 34257721
[TBL] [Abstract][Full Text] [Related]
8. Profiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients.
Zhang L; Wang J; Wei F; Wang K; Sun Q; Yang F; Jin H; Zheng Y; Zhao H; Wang L; Yu W; Zhang X; An Y; Yang L; Zhang X; Ren X
Oncotarget; 2016 Jul; 7(28):43604-43615. PubMed ID: 27283895
[TBL] [Abstract][Full Text] [Related]
9. Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers.
Zuo S; Wen Y; Panha H; Dai G; Wang L; Ren X; Fu K
Mol Immunol; 2017 May; 85():293-304. PubMed ID: 28360017
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy.
Li J; Chen L; Xiong Y; Zheng X; Xie Q; Zhou Q; Shi L; Wu C; Jiang J; Wang H
Cell Physiol Biochem; 2017; 41(3):907-920. PubMed ID: 28222426
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the proliferation, cytotoxic activity and cytokine secretion function of cascade primed immune cells and cytokine-induced killer cells in vitro.
Li GX; Zhao SS; Zhang XG; Wang WH; Liu J; Xue KW; Li XY; Guo YX; Wang LH
Mol Med Rep; 2015 Aug; 12(2):2629-35. PubMed ID: 25955083
[TBL] [Abstract][Full Text] [Related]
12. [The Effects of PKCι on Anti-tumor Activity of Cytokine-induced Killer Cells Against Pancreatic Cancer Cells and the Possible Underlying Mechanisms].
Zhang HM; Wang YR; Yang JH; Leng XH; Wang PP; Li ZX; Zhu TB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 50(6):821-826. PubMed ID: 31880112
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models.
Zheng Y; Hu B; Xie S; Chen X; Hu Y; Chen W; Li S; Hu B
Cytotherapy; 2017 May; 19(5):617-628. PubMed ID: 28215653
[TBL] [Abstract][Full Text] [Related]
14. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16.
Qian D; Chen K; Deng H; Rao H; Huang H; Liao Y; Sun X; Lu S; Yuan Z; Xie D; Cai Q
Clin Cancer Res; 2015 Nov; 21(21):4881-91. PubMed ID: 26100275
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-374b reduces the proliferation and invasion of colon cancer cells by regulation of LRH-1/Wnt signaling.
Qu R; Hao S; Jin X; Shi G; Yu Q; Tong X; Guo D
Gene; 2018 Feb; 642():354-361. PubMed ID: 29128635
[TBL] [Abstract][Full Text] [Related]
17. p53/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damage.
Gong H; Cao Y; Han G; Zhang Y; You Q; Wang Y; Pan Y
Int J Oncol; 2017 May; 50(5):1785-1791. PubMed ID: 28339062
[TBL] [Abstract][Full Text] [Related]
18. Polysaccharides from Hedyotis diffusa enhance the antitumor activities of cytokine-induced killer cells.
Ma C; Wei Y; Liu Q; Xin Y; Cao G; Wang X; Yang P
Biomed Pharmacother; 2019 Sep; 117():109167. PubMed ID: 31387180
[TBL] [Abstract][Full Text] [Related]
19. Cytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancer.
Yu B; Wang J; He C; Wang W; Tang J; Zheng R; Zhou C; Zhang H; Fu Z; Li Q; Xu J
Exp Ther Med; 2017 Jul; 14(1):831-840. PubMed ID: 28673007
[TBL] [Abstract][Full Text] [Related]
20. Blocking the PD-1/PD-L1 axis in dendritic cell-stimulated Cytokine-Induced Killer Cells with pembrolizumab enhances their therapeutic effects against hepatocellular carcinoma.
Zhang W; Song Z; Xiao J; Liu X; Luo Y; Yang Z; Luo R; Li A
J Cancer; 2019; 10(11):2578-2587. PubMed ID: 31258764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
